Welcome to Meril Life – A Global MedTech Company – Page 7 – Meril Life is a global medical device manufacturer offering best-in-class medical devices, Healthcare solutions worldwide.

Evermine50 – Drug Eluting Stent (DES) – Meril Vascular Intervention

EVERMINE50

Breakthrough in DES Technology:

Ultra-low strut thickness of 50μm for promoting early vascular healing
Variable strut width and variable crown design to ensure adequate radial strength of 1.1bar*
Hybrid cell stent design: Open cells in the middle of the stent for side-branch access and closed cell design on ends for optimal scaffolding and conformability
Clinically established drug everolimus with biodegradable polymer for proven clinical safety & long term efficacy

*Bench test data on file at Meril Life Sciences

Visit our website to learn more about the product.

BioMime – Drug Eluting Stent (DES) – Meril Vascular Intervention

BioMime^TM is a Sirolimus Eluting Coronary Stent System with an ultra-thin (65 µm) strut thickness.

This next generation (SES) has a Novel Hybrid Design with closed cells (on both ends of the stent) & open cells (in the middle)- this allows for Morphology Mediated Expansion for adequate conformability and lesser edge dissections.

BioPoly-Biodegradable Polymer: 2µm low thickness, stable and elastic polymer.

Stent design with non-linear S links & Y connectors allowing high flexibility and adequate side branch access. Strut width variability ensures optimal radial strength.

Low balloon over hang of less than 0.5mm to minimize healthy vessel injury.

Available in more than 94 Countries worldwide with more than 500,000 stents deployed.

meriT Trials: Consistent data in more than 1,700 patients upto 5 years follow-up.

Non Inferiority to XIENCE DES proven in meriT-V: published in Eurointervention (Sep’18)

Benefits of BioMime:

Ultra-thin 65 µm strut thickness & Biodegradable Polymer-Based DES for Faster Healing.
Strut Width Variability for Optimal Radial Strength & Conformability.
Morphology Mediated Expansion for Lesser Edge Dissections.
Novel Hybrid Cell Design with Open Cells in the Middle for Adequate Side Branch Access

Visit our website to learn more about the product.

Meril – Diagnostics

Meril Diagnostics is focused on translating excellence in science into effective diagnostics for patients and path labs. We combine cutting-edge research with global presence and reach in clinical development, manufacturing and commercial operations.

Meril Diagnostics stands strong with a wide portfolio of diagnostic range of products. We offer complete range of analyzers, reagents for clinical biochemistry, haematology, immunology (ELISA & CLIA), rapids, critical care, diabetes management, coagulation and lab consumables. Meril Diagnostics is one of the world’s leading manufacturers of 3 Part and 5 Part Haematology, Fully Auto Biochemistry 100/200/400 throughput Analyzers.

Meril’s Malaria range of products is amongst very few Indian kits approved by WHO. Not only this, our HIV range of products are CE marked and commercially used in many parts of Europe. We are proud to be the largest supplier partner of HIV kits for government of India.

Meril – Endosurgery

At Meril, we strive to create and develop products through innovative thinking, cutting edge technologies and collaboration with medical professionals and healthcare organizations with an aim to identify clinical needs and translate them into market leading solutions.

Meril Endosurgery is a one-stop solution for surgeons for providing an extensive product portfolio comprising of Absorbable & Non-absorbable Surgical Sutures, Tissue Sealants, Absorbable Hemostats, Hernia Repair (Mesh), Intrauterine Devices (Cu-T, Hormonal IUD), Energy Devices and Mechanical Closure Devices (Staplers).

Meril Endosurgery products are used in more than 100 countries and we have a rich pipeline to offer in coming years. Moreover, we provide hands-on training sessions at our Meril Academy to aspiring surgeons globally.

Meril – Orthopedics

The journey started 10 years ago when Meril acquired Maxx Medical, an established orthopaedic US device company. Since then there has been no looking back. We have pioneered path-breaking technology in manufacturing diverse orthopaedic portfolio. And with the support of world renowned surgeons, we have emerged as frontrunners in this segment.

Today, we offer a large range of innovative, orthopaedic implants from knee replacements to Hip replacements to Trauma along with revision portfolio. All our products are clinically backed by large number of clinical studies, enrolling patients globally and supported by team of global scientific advisors. Meril orthopaedic products are used in more than 50 countries restoring their mobility to suit their lifestyles and thus adding more to life, globally. Meril is committed to lead innovation by developing a strong pipeline, patient centric innovative products to offer in future.

Meril – Vascular Intervention

Meril Vascular Intervention has developed new concepts in engineering employing novel designs with a cleverly iterated diverse portfolio including devices ranging from drug eluting stents, bioresorbable scaffold, balloon catheter, peripheral vascular and transcatheter aortic valves replacement system (TAVR). All our products are clinically backed by large number of clinical studies, enrolling patients globally and supported by team of global scientific advisors.

Meril vascular intervention products are used in more than 100 countries. Unique and completely integrated manufacturing system ensures backward integration, flawless man-material movement, complete control over processes with strong validation. Meril is committed to lead innovation by developing a strong pipeline, patient centric innovative products to offer in future thus adding more to life globally.

Meril Clinical Program Overview

Along with dedication towards the design and development of novel, clinically relevant, state-of-the-art and best-in-class devices, Meril is deeply involved in conducting clinical trials to support their innovations that would further alleviate human sufferings. In addition to proving the safety and efficacy of our devices, we collaborate with the healthcare professionals worldwide to address the limitations in existing technologies as identified by them. We believe that it is our responsibility towards mankind to identify their needs and provide better quality of life with our devices.

Till date, clinical program of Meril has around 100 clinical studies that include 500+ healthcare professionals and consistent clinical data in 15000+ patients.

All the knowledge gathered through clinical research is diffused in the public domain through publications. Meril has 85+ publications for the devices of all the four verticals, namely cardiovascular, orthopaedic, endo-surgery and diagnostics. We greatly appreciate this privilege, and would like to welcome the healthcare professionals to find out more about recent clinical trials by Meril.